An update on APOA 1 published four days ago in NCBI
|
4
|
Resverlogix Corp.
|
Nov 21, 2018 03:57PM
|
Anemia of Chronic Inflammation/Anemia of Chronic Disease
|
5
|
Resverlogix Corp.
|
Sep 20, 2019 10:35PM
|
Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript
|
11
|
Zenith Epigenetics
|
Jan 05, 2021 07:19AM
|
Another - arthritis/inflammati... & other indications (including cardio) - RCGD 423
|
4
|
Resverlogix Corp.
|
Feb 13, 2018 05:08PM
|
Another article. Mechanism related.
|
3
|
Resverlogix Corp.
|
Jun 13, 2022 03:06PM
|
Another variation
|
13
|
Resverlogix Corp.
|
Mar 04, 2021 12:52AM
|
Another, but already on company site
|
3
|
Resverlogix Corp.
|
Apr 14, 2023 01:38PM
|
Another, but already on company site
|
2
|
Resverlogix Corp.
|
Apr 14, 2023 01:39PM
|
Any relation or possible future collab?
|
|
Resverlogix Corp.
|
Mar 19, 2021 12:00AM
|
Anybody ever post this link already?
|
7
|
Resverlogix Corp.
|
Apr 14, 2023 04:34AM
|
Anyone signed up for ESC 2021?
|
1
|
Resverlogix Corp.
|
Aug 08, 2021 03:42PM
|
Aortic Stenosis - inflammation etc.
|
|
Resverlogix Corp.
|
Aug 18, 2021 09:58PM
|
Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study (BRD4i)
|
6
|
Resverlogix Corp.
|
Sep 21, 2018 04:03AM
|
Apabetalone may reduce chemotherapy resistance in ovarian cancer
|
6
|
Resverlogix Corp.
|
Feb 27, 2021 11:29PM
|
Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 11:21PM
|
Apparently Don spoke other day, but not at ESC
|
4
|
Resverlogix Corp.
|
Aug 30, 2021 12:53AM
|
archived presentation is up. still no audio
|
1
|
Resverlogix Corp.
|
Nov 18, 2019 09:32AM
|
Article
|
10
|
Resverlogix Corp.
|
May 25, 2021 05:35AM
|
Article
|
5
|
Resverlogix Corp.
|
May 29, 2022 03:09PM
|
Article
|
7
|
Resverlogix Corp.
|
Mar 14, 2022 06:36PM
|